Literature DB >> 14751977

Identification of optimal classification functions for biological sample and state discrimination from metabolic profiling data.

Kyongbum Lee1, Daehee Hwang, Tadaaki Yokoyama, George Stephanopoulos, Gregory N Stephanopoulos, Martin L Yarmush.   

Abstract

MOTIVATIONS: Classification of biological samples for diagnostic purposes is a difficult task because of the many decisions involved on the number, type and functional manipulations of the input variables. This study presents a generally applicable strategy for systematic formulation of optimal diagnostic indexes. To this end, we develop a novel set of computational tools by integrating regression optimization, stepwise variable selection and cross-validation algorithms.
RESULTS: The proposed discrimination methodology was applied to plasma and tissue (liver) metabolic profiling data describing the time progression of liver dysfunction in a rat model of acute hepatic failure generated by d-galactosamine (GalN) injection. From the plasma data, our methodology identified seven (out of a total of 23) metabolites, and the corresponding transform functions, as the best inputs to the optimal diagnostic index. This index showed better time resolution and increased noise robustness compared with an existing metabolic index, Fischer's BCAA/AAA molar ratio, as well as indexes generated using other commonly used discriminant analysis tools. Comparison of plasma and liver indexes found two consensus metabolites, lactate and glucose, which implicate glycolysis and/or gluconeogenesis in mediating the metabolic effects of GalN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751977     DOI: 10.1093/bioinformatics/bth015

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  7 in total

1.  Predicting interpretability of metabolome models based on behavior, putative identity, and biological relevance of explanatory signals.

Authors:  David P Enot; Manfred Beckmann; David Overy; John Draper
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-21       Impact factor: 11.205

2.  Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.

Authors:  Yutaka Ihata; Etsuko Miyagi; Reiko Numazaki; Takahiko Muramatsu; Akira Imaizumi; Hiroshi Yamamoto; Minoru Yamakado; Naoyuki Okamoto; Fumiki Hirahara
Journal:  Int J Clin Oncol       Date:  2013-05-23       Impact factor: 3.402

3.  Diluted blood reperfusion as a model for transplantation of ischemic rat livers: alanine aminotransferase is a direct indicator of viability.

Authors:  K Uygun; H Tolboom; M L Izamis; B Uygun; N Sharma; H Yagi; A Soto-Gutierrez; M Hertl; F Berthiaume; M L Yarmush
Journal:  Transplant Proc       Date:  2010-09       Impact factor: 1.066

4.  Soft constraints-based multiobjective framework for flux balance analysis.

Authors:  Deepak Nagrath; Marco Avila-Elchiver; François Berthiaume; Arno W Tilles; Achille Messac; Martin L Yarmush
Journal:  Metab Eng       Date:  2010-05-27       Impact factor: 9.783

5.  Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.

Authors:  Jun Maeda; Masahiko Higashiyama; Akira Imaizumi; Tomio Nakayama; Hiroshi Yamamoto; Takashi Daimon; Minoru Yamakado; Fumio Imamura; Ken Kodama
Journal:  BMC Cancer       Date:  2010-12-22       Impact factor: 4.430

6.  The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer.

Authors:  Masato Shingyoji; Toshihiko Iizasa; Masahiko Higashiyama; Fumio Imamura; Nobuhiro Saruki; Akira Imaizumi; Hiroshi Yamamoto; Takashi Daimon; Osamu Tochikubo; Toru Mitsushima; Minoru Yamakado; Hideki Kimura
Journal:  BMC Cancer       Date:  2013-02-15       Impact factor: 4.430

7.  Resuscitation of ischemic donor livers with normothermic machine perfusion: a metabolic flux analysis of treatment in rats.

Authors:  Maria-Louisa Izamis; Herman Tolboom; Basak Uygun; Francois Berthiaume; Martin L Yarmush; Korkut Uygun
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.